HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox.

Abstract
While the smallpox vaccine, Dryvax or Dryvax-derived ACAM2000, holds potential for public immunization against the spread of smallpox by bioterror, there is serious concern about Dryvax-mediated side effects. Here, we report that a single-dose vaccination regimen comprised of Dryvax and an antiviral agent, cidofovir, could reduce vaccinia viral loads after vaccination and significantly control Dryvax vaccination side effects. However, coadministration of cidofovir and Dryvax also reduced vaccine-elicited immune responses of antibody and T effector cells despite the fact that the reduced priming could be boosted as a recall response after monkeypox virus challenge. Evaluations of four different aspects of vaccine efficacy showed that coadministration of cidofovir and Dryvax compromised the Dryvax-induced immunity against monkeypox, although the covaccinated monkeys exhibited measurable protection against monkeypox compared to that of naïve controls. Thus, the single-dose coadministration of cidofovir and Dryvax effectively controlled vaccination side effects but significantly compromised vaccine-elicited immune responses and vaccine-induced immunity to monkeypox.
AuthorsHuiyong Wei, Dan Huang, Jeff Fortman, Richard Wang, Linyun Shao, Zheng W Chen
JournalJournal of virology (J Virol) Vol. 83 Issue 2 Pg. 1115-25 (Jan 2009) ISSN: 1098-5514 [Electronic] United States
PMID19004937 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antibodies, Viral
  • Antiviral Agents
  • DryVax vaccine
  • Organophosphonates
  • Smallpox Vaccine
  • Cytosine
  • cidofovir
Topics
  • Animals
  • Antibodies, Viral (immunology)
  • Antiviral Agents (administration & dosage)
  • Cytosine (administration & dosage, analogs & derivatives)
  • Drug Incompatibility
  • Macaca fascicularis
  • Monkeypox (prevention & control)
  • Organophosphonates (administration & dosage)
  • Smallpox Vaccine (administration & dosage, adverse effects, immunology)
  • T-Lymphocytes (immunology)
  • Vaccinia (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: